Skip Navigation
Skip to contents

JYMS : Journal of Yeungnam Medical Science

Indexed in: ESCI, Scopus, PubMed,
PubMed Central, CAS, DOAJ, KCI
FREE article processing charge
OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Browse Articles > Author index
Search
Jung Min Bae 2 Articles
Pathophysiology and protective approaches of gut injury in critical illness
Chang Yeon Jung, Jung Min Bae
Yeungnam Univ J Med. 2021;38(1):27-33.   Published online September 23, 2020
DOI: https://doi.org/10.12701/yujm.2020.00703
  • 7,139 View
  • 202 Download
  • 6 Crossref
AbstractAbstract PDF
The gut is a complex organ that has played an important role in digestion, absorption, endocrine functions, and immunity. The gut mucosal barriers consist of the immunologic barrier and nonimmunologic barrier. During critical illnesses, the gut is susceptible to injury due to the induction of intestinal hyperpermeability. Gut hyperpermeability and barrier dysfunction may lead to systemic inflammatory response syndrome. Additionally, gut microbiota are altered during critical illnesses. The etiology of such microbiome alterations in critical illnesses is multifactorial. The interaction or systemic host defense modulation between distant organs and the gut microbiome is increasingly studied in disease research. No treatment modality exists to significantly enhance the gut epithelial integrity, permeability, or mucus layer in critically ill patients. However, multiple helpful approaches including clinical and preclinical strategies exist. Enteral nutrition is associated with an increased mucosal barrier in animal and human studies. The trophic effects of enteral nutrition might help to maintain the intestinal physiology, prevent atrophy of gut villi, reduce intestinal permeability, and protect against ischemia-reperfusion injury. The microbiome approach such as the use of probiotics, fecal microbial transplantation, and selective decontamination of the digestive tract has been suggested. However, its evidence does not have a high quality. To promote rapid hypertrophy of the small bowel, various factors have been reported, including the epidermal growth factor, membrane permeant inhibitor of myosin light chain kinase, mucus surrogate, pharmacologic vagus nerve agonist, immune-enhancing diet, and glucagon-like peptide-2 as preclinical strategies. However, the evidence remains unclear.

Citations

Citations to this article as recorded by  
  • Limonene Exerts Anti-Inflammatory Effect on LPS-Induced Jejunal Injury in Mice by Inhibiting NF-κB/AP-1 Pathway
    Sarmed H. Kathem, Yasameen Sh. Nasrawi, Shihab H. Mutlag, Surya M. Nauli
    Biomolecules.2024; 14(3): 334.     CrossRef
  • Bacillus licheniformis reverses the environmental ceftriaxone sodium-induced gut microbial dysbiosis and intestinal inflammation in mice
    Zhibo Zeng, Wen Yue, Cermon Kined, PengPeng Wang, Ran Liu, Jing Liu, Xinzhu Chen
    Ecotoxicology and Environmental Safety.2023; 257: 114890.     CrossRef
  • Severe gastrointestinal injury associated with SARS-CoV-2 infection: Thrombosis or Inflammation?: A retrospective case series study
    Henry Robayo-Amortegui, Alex Forero-Delgadillo, Michel Pérez-Garzón, Claudia Poveda-Henao, Conny Muñoz-Claros, Andrea Bayona-Solano, Carlos Orozco, Ricardo Buitrago-Bernal
    Medicine.2022; 101(42): e31188.     CrossRef
  • The Gut-Liver Axis in Cholestatic Liver Diseases
    Andreas Blesl, Vanessa Stadlbauer
    Nutrients.2021; 13(3): 1018.     CrossRef
  • The Role of DAMPS in Burns and Hemorrhagic Shock Immune Response: Pathophysiology and Clinical Issues. Review
    Desirè Pantalone, Carlo Bergamini, Jacopo Martellucci, Giovanni Alemanno, Alessandro Bruscino, Gherardo Maltinti, Maximilian Sheiterle, Riccardo Viligiardi, Roberto Panconesi, Tommaso Guagni, Paolo Prosperi
    International Journal of Molecular Sciences.2021; 22(13): 7020.     CrossRef
  • Safety of Using Enteral Nutrition Formulations Containing Dietary Fiber in Hospitalized Critical Care Patients: A Systematic Review and Meta‐Analysis
    Kelly Copeland Cara, Andrew R. Beauchesne, Taylor C. Wallace, Mei Chung
    Journal of Parenteral and Enteral Nutrition.2021; 45(5): 882.     CrossRef
Superficial malignant peripheral nerve sheath tumor from recurrent neurofibroma in the abdominal wall of a patient without neurofibromatosis type 1
Chang Yeon Jung, Jung Min Bae, Joon Hyuk Choi, Ki Hoon Jung
Yeungnam Univ J Med. 2019;36(1):63-66.   Published online December 20, 2018
DOI: https://doi.org/10.12701/yujm.2019.00031
  • 6,334 View
  • 100 Download
  • 1 Crossref
AbstractAbstract PDF
Malignant peripheral nerve sheath tumor (MPNST) is rare, accounting for 5–10% of all soft tissue sarcomas. MPNST is characteristically aggressive and has a poor prognosis. Fifty percent of patients with MPNST have neurofibromatosis type 1 (NF1). NF-associated MPNST (NF-MPNST) occurs more often at younger ages than sporadic MPNST (sMPNST), but the survival difference is controversial. Superficial MPNST from a recurrent neurofibroma is extremely rare and only a limited number of cases have been reported in the literature. Herein, we report an unusual case of superficial MPNST from a recurrent neurofibroma in a patient without NF1.

Citations

Citations to this article as recorded by  
  • Sporadic neurofibroma of transverse colon in a patient without neurofibromatosis type 1: A case report
    Toru Imagami, Saburo Sugita, Takaya Nagasaki, Masahiro Kimura, Keisuke Ito, Shingo Inaguma
    International Journal of Surgery Case Reports.2020; 71: 19.     CrossRef

JYMS : Journal of Yeungnam Medical Science